請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56704完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李苑玲(Yuan-Ling Lee),張曉華(Hsiao-Hua Chang) | |
| dc.contributor.author | Zih-Syun Hung | en |
| dc.contributor.author | 洪子薰 | zh_TW |
| dc.date.accessioned | 2021-06-16T05:43:15Z | - |
| dc.date.available | 2014-10-15 | |
| dc.date.copyright | 2014-10-15 | |
| dc.date.issued | 2014 | |
| dc.date.submitted | 2014-08-11 | |
| dc.identifier.citation | Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S (2007). Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International endodontic journal 40(4):261-267.
Agamy HA, Bakry NS, Mounir MM, Avery DR (2004). Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatric dentistry 26(4):302-309. American Academy of Paediatric Dentistry. Guideline on pulp therapy for primary and immature permanent teeth. Reference Manual 2009-10. Pediatric dentistry 2009;31: 179-84. Amir FA, Gutmann JL, Witherspoon DE (2001). Calcific metamorphosis: a challenge in endodontic diagnosis and treatment. Quintessence international 32(6):447-455. Ansari G, Ranjpour M (2010). Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up. International endodontic journal 43(5):413-418. Asgary S, Parirokh M, Eghbal MJ, Brink F (2005). Chemical differences between white and gray mineral trioxide aggregate. Journal of endodontics 31(2):101-103. Berger JE (1965). Pulp Tissue Reaction to Formocresol and Zinc Oxide-Eugenol. ASDC journal of dentistry for children 32(13-28. Bogen G, Kim JS, Bakland LK (2008). Direct pulp capping with mineral trioxide aggregate: an observational study. Journal of the American Dental Association 139(3):305-315; quiz 305-315. Caicedo R, Abbott PV, Alongi DJ, Alarcon MY (2006). Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth. Australian dental journal 51(4):297-305. Camilleri J, Montesin FE, Brady K, Sweeney R, Curtis RV, Ford TR (2005). The constitution of mineral trioxide aggregate. Dental materials : official publication of the Academy of Dental Materials 21(4):297-303. Camp JH (2008). Diagnosis dilemmas in vital pulp therapy: treatment for the toothache is changing, especially in young, immature teeth. Pediatric dentistry 30(3):197-205. Casas MJ, Kenny DJ, Johnston DH, Judd PL (2004). Long-term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric dentistry 26(1):44-48. Chacko V, Kurikose S (2006). Human pulpal response to mineral trioxide aggregate (MTA): a histologic study. The Journal of clinical pediatric dentistry 30(3):203-209. Coll JA (2008). Indirect pulp capping and primary teeth: is the primary tooth pulpotomy out of date? Pediatric dentistry 30(3):230-236. Cotes O, Boj JR, Canalda C, Carreras M (1997). Pulpal tissue reaction to formocresol vs. ferric sulfate in pulpotomized rat teeth. The Journal of clinical pediatric dentistry 21(3):247-253. de Vasconcelos BC, Bernardes RA, Cruz SM, Duarte MA, Padilha Pde M, Bernardineli N et al. (2009). Evaluation of pH and calcium ion release of new root-end filling materials. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 108(1):135-139. Doyle WA, McDonald RE, Mitchell DF. Formocresol versus calcium hydroxide in pulpotomy. ASDC J Dent Child 1962(29):86 –97. Doyle TL, Casas MJ, Kenny DJ, Judd PL (2010). Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric dentistry 32(1):41-47. Eidelman E, Holan G, Fuks AB (2001). Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric dentistry 23(1):15-18. Erdem AP, Guven Y, Balli B, Ilhan B, Sepet E, Ulukapi I et al. (2011). Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study. Pediatric dentistry 33(2):165-170. Farsi N, Alamoudi N, Balto K, Mushayt A (2005). Success of mineral trioxide aggregate in pulpotomized primary molars. The Journal of clinical pediatric dentistry 29(4):307-311. Fei AL, Udin RD, Johnson R (1991). A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric dentistry 13(6):327-332. Fernandez CC, Martinez SS, Jimeno FG, Lorente Rodriguez AI, Mercade M (2013). Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2-year follow-up. International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children 23(6):400-407. Ford TR, Torabinejad M, Abedi HR, Bakland LK, Kariyawasam SP (1996). Using mineral trioxide aggregate as a pulp-capping material. Journal of the American Dental Association 127(10):1491-1494. Frenkel G, Kaufman A, Ashkenazi M (2012). Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up. The Journal of clinical pediatric dentistry 37(2):137-141. Fuks AB, Bimstein E (1981). Clinical evaluation of diluted formocresol pulpotomies in primary teeth of school children. Pediatric dentistry 3(4):321-324. Fuks AB, Bimstein E, Bruchim A (1983). Radiographic and histologic evaluation of the effect of two concentrations of formocresol on pulpotomized primary and young permanent teeth in monkeys. Pediatric dentistry 5(1):9-13. Fuks AB, Bimstein E, Guelmann M, Klein H (1990). Assessment of a 2 percent buffered glutaraldehyde solution in pulpotomized primary teeth of schoolchildren. ASDC journal of dentistry for children 57(5):371-375. Fuks AB, Holan G, Davis JM, Eidelman E (1997). Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long-term follow up. Pediatric dentistry 19(5):327-330. Fuks AB (2000). Pulp therapy for the primary and young permanent dentitions. Dental clinics of North America 44(3):571-596, vii. Fuks AB (2002). Current concepts in vital primary pulp therapy. European journal of paediatric dentistry : official journal of European Academy of Paediatric Dentistry 3(3):115-120. Fuks AB (2008). Vital pulp therapy with new materials for primary teeth: new directions and Treatment perspectives. Pediatric dentistry 30(3):211-219. Fuks AB and Guelmann M(2012). Pulp Therapy for the primary Dentition. Pediatric dentistry: infancy through adolescence. 5e: 333-348 Holan G, Fuks AB, Ketlz N (2002). Success rate of formocresol pulpotomy in primary molars restored with stainless steel crown vs amalga. Pediatric dentistry 24(3):212-216. Holan G, Eidelman E, Fuks AB (2005). Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric dentistry 27(2):129-136. Holland R, Sant'Anna Junior A, Souza V, Dezan Junior E, Otoboni Filho JA, Bernabe PF et al. (2005). Influence of apical patency and filling material on healing process of dogs' teeth with vital pulp after root canal therapy. Brazilian dental journal 16(1):9-16. Hutcheson C, Seale NS, McWhorter A, Kerins C, Wright J (2012). Multi-surface composite vs stainless steel crown restorations after mineral trioxide aggregate pulpotomy: a randomized controlled trial. Pediatric dentistry 34(7):460-467. Huth KC, Paschos E, Hajek-Al-Khatar N, Hollweck R, Crispin A, Hickel R et al. (2005). Effectiveness of 4 pulpotomy techniques--randomized controlled trial. Journal of dental research 84(12):1144-1148. Ibricevic H, al-Jame Q (2000). Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. The Journal of clinical pediatric dentistry 24(4):269-272. King SR, McWhorter AG, Seale NS (2002). Concentration of formocresol used by pediatric dentists in primary tooth pulpotomy. Pediatric dentistry 24(2):157-159. Kurji ZA, Sigal MJ, Andrews P, Titley K (2011). A retrospective study of a modified 1-minute formocresol pulpotomy technique part 2: effect on exfoliation times and successors. Pediatric dentistry 33(2):139-143. Lewis B (1998). Formaldehyde in dentistry: a review for the millennium. The Journal of clinical pediatric dentistry 22(2):167-177. Lin PY, Chen HS, Wang YH, Tu YK (2014). Primary molar pulpotomy: A systematic review and network meta-analysis. Journal of dentistry. Markovic D, Zivojinovic V, Vucetic M (2005). Evaluation of three pulpotomy medicaments in primary teeth. European journal of paediatric dentistry : official journal of European Academy of Paediatric Dentistry 6(3):133-138. Maroto M, Barberia E, Planells P, Garcia Godoy F (2005). Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. American journal of dentistry 18(3):151-154. Mejare I (1979). Pulpotomy of primary molars with coronal or total pulpitis using formocresol technique. Scandinavian journal of dental research 87(3):208-216. Mettlach SE, Zealand CM, Botero TM, Boynton JR, Majewski RF, Hu JC (2013). Comparison of mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars: 42-month follow-up and survival analysis. Pediatric dentistry 35(3):E87-94. Milnes AR (2006). Persuasive evidence that formocresol use in pediatric dentistry is safe. Journal 72(3):247-248. Mitchell PJ, Pitt Ford TR, Torabinejad M, McDonald F (1999). Osteoblast biocompatibility of mineral trioxide aggregate. Biomaterials 20(2):167-173. Maroto M, Barberia E, Planells P, Garcia Godoy F (2005). Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. American journal of dentistry 18(3):151-154. Morawa AP, Straffon LH, Han SS, Corpron RE (1975). Clinical evaluation of pulpotomies using dilute formocresol. ASDC journal of dentistry for children 42(5):360-363. Moretti AB, Oliveira TM, Sakai VT, Santos CF, Machado MA, Abdo RC (2007). Mineral trioxide aggregate pulpotomy of a primary second molar in a patient with agenesis of the permanent successor. International endodontic journal 40(9):738-745. Naik S, Hegde AH (2005). Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry 23(1):13-16. Noorollahian H (2008). Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. British dental journal 204(11):E20. Papagiannoulis L (2002). Clinical studies on ferric sulphate as a pulpotomy medicament in primary teeth. European journal of paediatric dentistry : official journal of European Academy of Paediatric Dentistry 3(3):126-132. Patel R, Cohenca N (2006). Maturogenesis of a cariously exposed immature permanent tooth using MTA for direct pulp capping: a case report. Dental traumatology : official publication of International Association for Dental Traumatology 22(6):328-333. Peng L, Ye L, Tan H, Zhou X (2006). Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 102(6):e40-44. Pruhs RJ, Olen GA, Sharma PS (1977). Relationship between formocresol pulpotomies on primary teeth and enamel defects on their permanent successors. Journal of the American Dental Association 94(4):698-700. Ranly DM, Garcia-Godoy F (2000). Current and potential pulp therapies for primary and young permanent teeth. Journal of dentistry 28(3):153-161. Rolling I, Thylstrup A (1975). A 3-year clinical follow-up study of pulpotomized primary molars treated with the formocresol technique. Scandinavian journal of dental research 83(2):47-53. Ruby JD, Cox CF, Mitchell SC, Makhija S, Chompu-Inwai P, Jackson J (2013). A randomized study of sodium hypochlorite versus formocresol pulpotomy in primary molar teeth. International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children 23(2):145-152. Salako N, Joseph B, Ritwik P, Salonen J, John P, Junaid TA (2003). Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat molar. Dental traumatology : official publication of International Association for Dental Traumatology 19(6):314-320. Schroder U (1978). A 2-year follow-up of primary molars, pulpotomized with a gentle technique and capped with calcium hydroxide. Scandinavian journal of dental research 86(4):273-278. Smith NL, Seale NS, Nunn ME (2000). Ferric sulfate pulpotomy in primary molars: a retrospective study. Pediatric dentistry 22(3):192-199. Sonmez D, Sari S, Cetinbas T (2008). A Comparison of four pulpotomy techniques in primary molars: a long-term follow-up. Journal of endodontics 34(8):950-955. Subramaniam P, Konde S, Mathew S, Sugnani S (2009). Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. The Journal of clinical pediatric dentistry 33(4):311-314. Sushynski JM, Zealand CM, Botero TM, Boynton JR, Majewski RF, Shelburne CE et al. (2012). Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation. Pediatric dentistry 34(5):120-128. Torabinejad M, Hong CU, McDonald F, Pitt Ford TR (1995). Physical and chemical properties of a new root-end filling material. Journal of endodontics 21(7):349-353. Torabinejad M, Hong CU, Lee SJ, Monsef M, Pitt Ford TR (1995). Investigation of mineral trioxide aggregate for root-end filling in dogs. Journal of endodontics 21(12):603-608. Torabinejad M, Pitt Ford TR, McKendry DJ, Abedi HR, Miller DA, Kariyawasam SP (1997). Histologic assessment of mineral trioxide aggregate as a root-end filling in monkeys. Journal of endodontics 23(4):225-228. Torabinejad M, Chivian N (1999). Clinical applications of mineral trioxide aggregate. Journal of endodontics 25(3):197-205. Vargas KG, Packham B, Lowman D (2006). Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric dentistry 28(6):511-517. Vostatek SF, Kanellis MJ, Weber-Gasparoni K, Gregorsok RL (2011). Sodium hypochlorite pulpotomies in primary teeth: a retrospective assessment. Pediatric dentistry 33(4):327-332. Waterhouse PJ, Nunn JH, Whitworth JM (2000). An investigation of the relative efficacy of Buckley's Formocresol and calcium hydroxide in primary molar vital pulp therapy. British dental journal 188(1):32-36. Watts A, Paterson RC (1987). Pulpal response to a zinc oxide-eugenol cement. International endodontic journal 20(2):82-86. Willard RM (1976). Radiographic changes following formocresol pulpotomy in primary molars. ASDC journal of dentistry for children 43(6):414-415. Witherspoon DE (2008). Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth. Pediatric dentistry 30(3):220-224. Zealand CM, Briskie DM, Botero TM, Boynton JR, Hu JC (2010). Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatric dentistry 32(5):393-399. Zurn D, Seale NS (2008). Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric dentistry 30(1):34-41. 張欣怡-台大臨床牙醫學研究所:MTA與DFC對於乳牙冠髓切除術治療療效評估之臨床試驗研究,2011 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56704 | - |
| dc.description.abstract | 本研究為前瞻性隨機分派臨床長期試驗,目的為探討灰色三氧礦化聚合物(Gray Mineral Trioxide Aggregate,GMTA)是否可取代傳統的20% 稀釋甲酚甲醛(20% Diluted formocresal,DFC)成為乳臼齒冠髓切除術的理想材料,並分析兩種材料治療失敗的狀況。本研究招募自2009年12月至2013年6月30日止,於台灣大學附設醫院牙科部兒童牙科求診的健康正常孩童,有效受試者有103人(年齡介於2.8歲至9.9歲),共249顆乳臼齒(DFC組有122顆,GMTA組有127顆),三年內的回診率皆大於七成以上。在GMTA組,術後三年內的臨床治療成功率為100%,而DFC組有牙齒表現發生膿腫而拔除,臨床治療成功率為96~100%,兩個組別在臨床成功率並未有統計上的顯著差異。在放射線學成功率方面,GMTA組在3年內的成功率均大於九成以上(94%-99%),而DFC組的成功率則從第1年回診的88%,逐年降低至第3年回診追蹤的67%,在所有追蹤期間內,兩個組別在放射線學成功率有統計上的顯著差異(p≤0.006)。其中兩組材料在發生牙本質屏障、根管鈣化及牙根內吸收變化的分布有統計上的顯著差異。在牙齒接受治療至脫落或被拔除的存活分析,DFC組的存活曲線下降的情況比GMTA組要明顯,檢定統計值接近顯著差異(p=0.054)。而在牙齒接受治療至發生放射線學失敗的存活分析,DFC組有較多牙齒發生放射線學失敗,DFC組的存活率明顯低於GMTA組(p<0.001)。而在組織學分析結果,GMTA組可以觀察到牙本質屏障生成、根管鈣化及完整的造牙本質細胞層,而DFC組觀察到牙根內吸收造成的陷窩、發炎細胞浸潤、組織和材料接觸的表面有異物反應。綜合本研究結果,在臨床發現、放射線學檢查結果以及組織學分析結果,GMTA療效明顯優於DFC,因此GMTA應具潛力取代DFC作為乳牙冠髓切除術的治療材料。 | zh_TW |
| dc.description.abstract | The purpose of this study is to establish a long-term prospective clinical randomized controlled trial (CRT) for assessing the clinical, radiographic, and histological outcomes between gray mineral trioxide aggregate (GMTA) and dilute 20% formocresol (DFC) in pulpotomized human primary molars. To assess this goal, 249 primary molars from 2.8 to 9.9 year-old patients of Department of Pediatric Dentistry of National Taiwan University Hospital were randomly assigned to GMTA group or DFC group. The recall rates within 3-year follow-up period were over 70%. Clinical success was 100% in GMTA group and 96~100% in DFC group because some teeth were exacted due to abscess formation. There is no significant difference in the clinical success rate between GMTA and DFC groups. The radiographic success rate of GMTA group (94% - 99%) were significant higher than that of DFC group (1-year: 86%, 3-year: 67%) at all follow-up periods (p≤0.006). More teeth with dentinal bridge were found in the GMTA group than in the DFC group at all follow-up periods. More teeth with pulp canal obliteration were observed in the DFC group than in the GMTA group within 24-month follow-up. Teeth with internal root resoprtion were only found in DFC. Survival analysis demonstrated that teeth treated with DFC were less likely to survive than teeth treated with GMTA (p=0.054) and DFC treated teeth presented lower survival rate than the GMTA treated teeth in radiographic evaluation. In addition, GMTA demonstrated dentin bridge formation, obliteration of the pulp canal, and regeneration of odontoblasts beneath GMTA histologically. In DFC group, the findings of Howship’s lacunae due to internal root resorption, foreign body reaction to filling material, and infiltration of inflammatory cells were observed. Based on the results of this study, GMTA appears to be a better pulpotomy agent than DFC in primary dentition. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T05:43:15Z (GMT). No. of bitstreams: 1 ntu-103-R00422008-1.pdf: 7735331 bytes, checksum: 017c40de36f30d69226938831fd4dd86 (MD5) Previous issue date: 2014 | en |
| dc.description.tableofcontents | 謝誌…………………………………………………………………………………....I
中文摘要……………………………..…………….…………………………………II 英文摘要………………………………...……………….…...……………………...III 目錄…………………………………………………………………………………...V 圖次…………………………………………………………….…………….…….VIII 表次…………………………………………………………………………….……..X 英文縮寫與中文對照表………………………………………………..……………..1 第一章 前言……………………………….………………………………………….2 第二章 文獻回顧…………………………………………………………….……….3 第一節 乳牙活髓治療……………………………………….…...….……...3 第二節 乳牙冠髓治療材料與技術……...………………………..………...4 第三節 FC的應用與現況術…………….………………………..………...6 第四節 MTA的應用與現況……………………………………..………….7 第五節 MTA與FC於乳牙冠髓切除術之臨床相關試驗…………….…...9 第三章 研究動機與目的……………………………………………………….…...12 第四章 材料與方法…………………………………………………………….…...13 第一節 研究對象…………………………………………..………….…...13 第二節 臨床試驗分組與治療流程………………………………………..14 第三節 追蹤回診及治療結果評估………………………………………..15 3.1 臨床評估………………………………………………………...15 3.2 放射線學評估…………………………………………………...16 3.3 組織學評估……………………………………………………...16 第四節 統計分析…………………………………………………………..17 第五章 結果……………………………………………………………………........19 第一節 受試者與樣本特性統計分析…………………..…………………..19 1.1 年齡……..…………………………………………………….....19 1.2 性別……………………………………………………………...20 1.3 受試者的配合程度…………………………………………...…20 1.4 牙弓位置……………………………………………………...…20 1.5 乳臼齒類型…………………………………………………...…21 1.6 治療醫師……………………………………………………...…21 1.7 牙髓組織狀態…………………………………………………...21 1.8 小結……………………………………………………………...22 第二節 樣本特性之相關性分析…………………………………..............22 第三節 回診樣本特性分析……………………………………………..…23 3.1 6個月回診檢查結果…………………………………………..23 3.2 12個月回診檢查結果…………………………………………24 3.3 18個月回診檢查結果…………………………………………24 3.4 24個月回診檢查結果…………………………………………24 3.5 30個月回診檢查結果…………………………………………24 3.6 36個月回診檢查結果…………………………………………25 第四節 臨床檢查結果與統計分析……………………………………..…25 4.1 6個月臨床檢查結果…………………………………………..25 4.2 12個月臨床檢查結果…………………………………………26 4.3 18個月臨床檢查結果…………………………………………26 4.4 24個月臨床檢查結果…………………………………………26 4.5 30個月臨床檢查結果…………………………………………27 4.6 36個月臨床檢查結果…………………………………………27 4.7 臨床回診發現與時間變化…………………………..………...27 第五節 放射線學檢查結果與統計分析………………………………..…27 5.1 6個月放射線學檢查結果……………………………………..27 5.2 12個月放射線學檢查結果……………………………….…...28 5.3 18個月放射線學檢查結果………………………………..…..29 5.4 24個月放射線學檢查結果…………………..………………..30 5.5 30個月放射線學檢查結果…………………………..………..31 5.6 36個月放射線學檢查結果………………………..…………..32 5.7 回診檢查發現對於時間之變化…………………..…………...33 5.8 放射線學失敗病例分析…………………………..…………..34 第六節 存活分析………………………………………………………..…36 6.1 發生牙齒脫落之存活分析……………………………...….…..36 6.2 發生放射線學失敗之存活分析………………………..…..…..37 6.3 接受DFC冠髓切除術乳臼齒發生放射線學失敗之預後分析..38 第七節 組織學發現………………………………………………………..39 第六章 討論……………………………………………………………………....41 第一節 研究設計與樣本分布…………………………….…………….41 第二節 臨床療效……………….……………………….………………42 第三節 放射線學療效………………………………….………….……43 第四節 放射線學發現…….…………………………….………………46 第五節 存活分析結果…….…………………………….………………52 第六節 組織學分析結果討論…………………………………………..54 第七節 預後與病因探討…………………………………………….….56 7.1 GMTA組……………………….…………….………..…..…..56 7.2 DFC組………………………….……………………....…..…..56 第七章 結論…..………………………………………………………………...…...57 參考文獻……………………………………………...……………………………...58 | |
| dc.language.iso | zh-TW | |
| dc.subject | 甲酚甲醛 | zh_TW |
| dc.subject | 三氧礦化聚合物 | zh_TW |
| dc.subject | 冠髓切除術 | zh_TW |
| dc.subject | 乳臼齒 | zh_TW |
| dc.subject | 臨床隨機試驗 | zh_TW |
| dc.subject | Primary molar | en |
| dc.subject | Mineral trioxide aggregate | en |
| dc.subject | Pulpotomy | en |
| dc.subject | Randomized clinical trial | en |
| dc.subject | Formocresol | en |
| dc.title | MTA和DFC應用於乳牙冠髓切除術之長期臨床試驗結果與預後探討 | zh_TW |
| dc.title | Comparison of Mineral Trioxide Aggregate and Diluted Formocresol in Pulpotomized Human Primary Molars: A Long-Term Follow-Up Study and Prognosis Investigation | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 郭敏光,劉正芬,江俊斌 | |
| dc.subject.keyword | 甲酚甲醛,三氧礦化聚合物,冠髓切除術,乳臼齒,臨床隨機試驗, | zh_TW |
| dc.subject.keyword | Formocresol,Mineral trioxide aggregate,Pulpotomy,Primary molar,Randomized clinical trial, | en |
| dc.relation.page | 115 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2014-08-12 | |
| dc.contributor.author-college | 牙醫專業學院 | zh_TW |
| dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
| 顯示於系所單位: | 臨床牙醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-103-1.pdf 未授權公開取用 | 7.55 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
